Published Date: 17 Mar 2023
UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
Researchers identify a novel biomarker linked to renal cancer recurrence
2.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
3.
Brexpiprazole Safe, Effective in Early-Episode Schizophrenia
4.
A Lot Can Be Said About You by Including Yourself in Photos.
5.
The Effect of Common Steroids on Cancer Treatments.
1.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
2.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
3.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
4.
Longitudinal Monitoring in Hematologic Care Pathways
5.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
3.
Future of Hematology
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation